Stock listing
9L40 Stock Price, News, Filings & Events — Ginkgo Bioworks Holdings, Inc.
Selected listing: 9L40 · TRADEGATE · EUR · DE
This page tracks Ginkgo Bioworks Holdings, Inc.'s 9L40:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 9L40:TRADEGATE. 9L40:TRADEGATE is the stock-level entry point for investors researching Ginkgo Bioworks Holdings, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 9L40:TRADEGATE
- Asset type
- Stock
- Market cap
- $498.3M
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- Exchange
- TRADEGATE
- Currency
- EUR
Ginkgo Bioworks Holdings, Inc. 9L40:TRADEGATE stock context
This page tracks Ginkgo Bioworks Holdings, Inc.'s 9L40:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 9L40:TRADEGATE. 9L40:TRADEGATE is the stock-level entry point for investors researching Ginkgo Bioworks Holdings, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Ginkgo Bioworks Holdings, Inc.
Genentech Announces Manufacturing Expansion in Hillsboro, Oregon
August 20, 2026
Ginkgo Bioworks : Expands Autonomous Lab Network to Caltech, MIT, Maryland and Northwestern
August 5, 2026
Ginkgo Bioworks : and Acies Bio Partner to Expand Global Access to High-Performance Aspergillus niger Strains for Protein Production
August 3, 2026
Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic P...
May 26, 2026
Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab
May 7, 2026
Research Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc. investor report
Review AI stock analysis and investor report context for 9L40:TRADEGATE.
Ginkgo Bioworks Holdings, Inc. company profile
View the public company page for Ginkgo Bioworks Holdings, Inc. on 6ix.
Ginkgo Bioworks Holdings, Inc. news
Read company news and market updates connected to Ginkgo Bioworks Holdings, Inc..
Ginkgo Bioworks Holdings, Inc. investor events
Find investor webinars, events, and replay context for Ginkgo Bioworks Holdings, Inc..
Alternate listings
DNA:NYSE
US · USD
Alternate listing for Ginkgo Bioworks Holdings, Inc.; the primary context on this page is 9L40:TRADEGATE.
DNA:BMV
MX · MXN
Alternate listing for Ginkgo Bioworks Holdings, Inc.; the primary context on this page is 9L40:TRADEGATE.
DNA:BOATS
US · USD
Alternate listing for Ginkgo Bioworks Holdings, Inc.; the primary context on this page is 9L40:TRADEGATE.
A40KL9:GETTEX
DE · EUR
Alternate listing for Ginkgo Bioworks Holdings, Inc.; the primary context on this page is 9L40:TRADEGATE.
DNA:BIVA
MX · MXN
Alternate listing for Ginkgo Bioworks Holdings, Inc.; the primary context on this page is 9L40:TRADEGATE.